This last result is particularly interesting when considering that ERβ can bind directly to TP53 and TP63 in BC cells and that, in the presence of mutant TP53, it interferes with its activity on target genes, resulting in inhibition of epithelial-to-mesenchymal transition and cell invasiveness [35]. Here, TP63 is linked to breast cancer.